| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3648721
[patent_doc_number] => 05639744
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-17
[patent_title] => 'Bile acids derivatives useful in the therapy of the biliary calculosis from cholesterol and of the pathologies caused by cholestasis'
[patent_app_type] => 1
[patent_app_number] => 8/416155
[patent_app_country] => US
[patent_app_date] => 1995-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8128
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/639/05639744.pdf
[firstpage_image] =>[orig_patent_app_number] => 416155
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/416155 | Bile acids derivatives useful in the therapy of the biliary calculosis from cholesterol and of the pathologies caused by cholestasis | Apr 3, 1995 | Issued |
| 08/413729 | 1-SUBSTITUTED VITAMIN D3 ANALOGUES | Mar 30, 1995 | Abandoned |
Array
(
[id] => 3828107
[patent_doc_number] => 05760025
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses'
[patent_app_type] => 1
[patent_app_number] => 8/414909
[patent_app_country] => US
[patent_app_date] => 1995-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37689
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 672
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/760/05760025.pdf
[firstpage_image] =>[orig_patent_app_number] => 414909
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/414909 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | Mar 30, 1995 | Issued |
Array
(
[id] => 3695730
[patent_doc_number] => 05661141
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => '19-oxygenated steroids as therapeutic agents'
[patent_app_type] => 1
[patent_app_number] => 8/409832
[patent_app_country] => US
[patent_app_date] => 1995-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10867
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661141.pdf
[firstpage_image] =>[orig_patent_app_number] => 409832
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/409832 | 19-oxygenated steroids as therapeutic agents | Mar 26, 1995 | Issued |
Array
(
[id] => 3564317
[patent_doc_number] => 05525745
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-11
[patent_title] => 'Intermediates in the preparation of 19-nor vitamin D compounds'
[patent_app_type] => 1
[patent_app_number] => 8/410858
[patent_app_country] => US
[patent_app_date] => 1995-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5119
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 319
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/525/05525745.pdf
[firstpage_image] =>[orig_patent_app_number] => 410858
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/410858 | Intermediates in the preparation of 19-nor vitamin D compounds | Mar 26, 1995 | Issued |
Array
(
[id] => 3493510
[patent_doc_number] => 05561125
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-01
[patent_title] => 'Estradiol derivative and growth inhibiting composition thereof'
[patent_app_type] => 1
[patent_app_number] => 8/408381
[patent_app_country] => US
[patent_app_date] => 1995-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6340
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/561/05561125.pdf
[firstpage_image] =>[orig_patent_app_number] => 408381
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/408381 | Estradiol derivative and growth inhibiting composition thereof | Mar 21, 1995 | Issued |
| 08/408392 | NOVEL ESTRADIOL DERIVATIVE-ALKYLATING AGENT CONJUGATE WITH REDUCED HORMONAL ACTIVITY, PROCESS FOR PREPARING THE SAME COMPOUNDS USEFUL FOR THE PREPARATION THEREOF, AND GROWTH INHIBITING COMPOSITION CONTAINING THE CONJUGATE OR ESTRADIOL DERIVATIVE | Mar 21, 1995 | Abandoned |
Array
(
[id] => 3540172
[patent_doc_number] => 05480878
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-02
[patent_title] => 'Method for treating prostatic hypertrophy with estradiol derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/408389
[patent_app_country] => US
[patent_app_date] => 1995-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6348
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/480/05480878.pdf
[firstpage_image] =>[orig_patent_app_number] => 408389
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/408389 | Method for treating prostatic hypertrophy with estradiol derivatives | Mar 21, 1995 | Issued |
Array
(
[id] => 3580468
[patent_doc_number] => 05491138
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-02-13
[patent_title] => 'Estradiol derivative alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative'
[patent_app_type] => 1
[patent_app_number] => 8/407962
[patent_app_country] => US
[patent_app_date] => 1995-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6351
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/491/05491138.pdf
[firstpage_image] =>[orig_patent_app_number] => 407962
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/407962 | Estradiol derivative alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative | Mar 21, 1995 | Issued |
Array
(
[id] => 3492617
[patent_doc_number] => 05536713
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-16
[patent_title] => '19-Nor-vitamin D.sub.3 compounds with substitutent at 2-position'
[patent_app_type] => 1
[patent_app_number] => 8/406646
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8605
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/536/05536713.pdf
[firstpage_image] =>[orig_patent_app_number] => 406646
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/406646 | 19-Nor-vitamin D.sub.3 compounds with substitutent at 2-position | Mar 19, 1995 | Issued |
Array
(
[id] => 3625334
[patent_doc_number] => 05602248
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'Process for preparation of 9.alpha.-chloro-11.beta.-formyloxypregna-3,20-diones'
[patent_app_type] => 1
[patent_app_number] => 8/405110
[patent_app_country] => US
[patent_app_date] => 1995-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3506
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 407
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/602/05602248.pdf
[firstpage_image] =>[orig_patent_app_number] => 405110
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/405110 | Process for preparation of 9.alpha.-chloro-11.beta.-formyloxypregna-3,20-diones | Mar 15, 1995 | Issued |
Array
(
[id] => 3686674
[patent_doc_number] => 05663157
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-02
[patent_title] => '22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents'
[patent_app_type] => 1
[patent_app_number] => 8/362438
[patent_app_country] => US
[patent_app_date] => 1995-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7338
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/663/05663157.pdf
[firstpage_image] =>[orig_patent_app_number] => 362438
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/362438 | 22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents | Mar 15, 1995 | Issued |
| 08/405472 | PROCESS FOR PREPARATION OF 9ALPHA-CHLORO-11BETA-FORMYLOXYPREGNA-3, 20-DIONES | Mar 15, 1995 | Abandoned |
Array
(
[id] => 3698313
[patent_doc_number] => 05596110
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-21
[patent_title] => 'Process for the preparation of 3 .beta., 14 .beta.-dihydroxyethianaldehyde'
[patent_app_type] => 1
[patent_app_number] => 8/405354
[patent_app_country] => US
[patent_app_date] => 1995-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1205
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/596/05596110.pdf
[firstpage_image] =>[orig_patent_app_number] => 405354
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/405354 | Process for the preparation of 3 .beta., 14 .beta.-dihydroxyethianaldehyde | Mar 15, 1995 | Issued |
Array
(
[id] => 3555944
[patent_doc_number] => 05519153
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-21
[patent_title] => 'Medrogestone production'
[patent_app_type] => 1
[patent_app_number] => 8/403312
[patent_app_country] => US
[patent_app_date] => 1995-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3652
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/519/05519153.pdf
[firstpage_image] =>[orig_patent_app_number] => 403312
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/403312 | Medrogestone production | Mar 13, 1995 | Issued |
Array
(
[id] => 3577013
[patent_doc_number] => 05523427
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-04
[patent_title] => 'Medrogestone production'
[patent_app_type] => 1
[patent_app_number] => 8/403314
[patent_app_country] => US
[patent_app_date] => 1995-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3653
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/523/05523427.pdf
[firstpage_image] =>[orig_patent_app_number] => 403314
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/403314 | Medrogestone production | Mar 13, 1995 | Issued |
| 08/394850 | HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1 ALPHA-HYDROXYLATED DERIVATIVES | Feb 26, 1995 | Abandoned |
Array
(
[id] => 3499058
[patent_doc_number] => 05532391
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-02
[patent_title] => 'Homologated vitamin D.sub.2 compounds and the corresponding 1.alpha.-hydroxylated derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/394579
[patent_app_country] => US
[patent_app_date] => 1995-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10365
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/532/05532391.pdf
[firstpage_image] =>[orig_patent_app_number] => 394579
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/394579 | Homologated vitamin D.sub.2 compounds and the corresponding 1.alpha.-hydroxylated derivatives | Feb 26, 1995 | Issued |
Array
(
[id] => 3601180
[patent_doc_number] => 05559257
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-24
[patent_title] => 'Process for the preparation of tetrachloro-1,4-benzoquinone'
[patent_app_type] => 1
[patent_app_number] => 8/392469
[patent_app_country] => US
[patent_app_date] => 1995-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5245
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/559/05559257.pdf
[firstpage_image] =>[orig_patent_app_number] => 392469
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/392469 | Process for the preparation of tetrachloro-1,4-benzoquinone | Feb 21, 1995 | Issued |
Array
(
[id] => 3547097
[patent_doc_number] => 05554774
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-10
[patent_title] => 'Preparation of chlorinated violanthrones or isoviolanthrones'
[patent_app_type] => 1
[patent_app_number] => 8/386665
[patent_app_country] => US
[patent_app_date] => 1995-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1294
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/554/05554774.pdf
[firstpage_image] =>[orig_patent_app_number] => 386665
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/386665 | Preparation of chlorinated violanthrones or isoviolanthrones | Feb 9, 1995 | Issued |